Cargando…
Intravenous tirofiban therapy for patients with capsular warning syndrome
BACKGROUND: Capsular warning syndrome (CWS) is defined as recurrent episodes of transient ischaemic attacks ≥3 times during a short time frame. There is no effective therapy to stop these attacks. We, herein, report our experience of using intravenous tirofiban to treat CWS. METHODS: All patients wi...
Autores principales: | Li, Wei, Wu, Ya, Li, Xiao-Shu, Liu, Cheng-Chun, Huang, Shu-Han, Liang, Chun-Rong, Wang, Huan, Zhang, Li-Li, Xu, Zhi-Qiang, Wang, Yan-Jiang, Zhang, Meng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475082/ https://www.ncbi.nlm.nih.gov/pubmed/31105975 http://dx.doi.org/10.1136/svn-2018-000163 |
Ejemplares similares
-
Correction: Intravenous tirofiban therapy for patients with capsular warning syndrome
Publicado: (2019) -
Clinical safety and possible efficacy of tirofiban in combination with intravenous thrombolysis by recombinant tissue plasminogen activator for early treatment of capsular warning syndrome (CWS)
por: Liu, Yunzhu, et al.
Publicado: (2022) -
Capsular warning syndrome: clinical analysis and treatment
por: He, Lanying, et al.
Publicado: (2019) -
Prospective pilot study of tirofiban in progressive stroke after intravenous thrombolysis
por: Zhang, Yan, et al.
Publicado: (2022) -
Idiopathic hypereosinophilic syndrome presenting as capsular warning syndrome: A case report and literature review
por: Lai, Ze-Hua, et al.
Publicado: (2023)